Literature DB >> 20370468

Effects of L-Dopa on circadian rhythms of 6-OHDA striatal lesioned rats: a radiotelemetric study.

Audrey Boulamery1, Nicolas Simon, Johanna Vidal, Bernard Bruguerolle.   

Abstract

Temporal variation in the motor function of Parkinson's disease (PD) patients suggests the potential importance of a chronobiological and chronopharmacological approach in its clinical management. We previously documented the effects of striatal injection of 6-OHDA (as an animal model of PD) on the circadian rhythms of temperature (T), heart rate (HR), and locomotor activity (A). The present work assessed the possible influence of L-Dopa on these same rhythms in the 6-OHDA animal model of PD. The study began after a four-week recovery period following surgical implantation of telemetric devices to monitor the study variables and/or anaesthesia. The study was divided into an initial one-week control period (W1) for baseline measurement of T, HR, and A rhythms. Thereafter, stereotaxic 6-OHDA lesioning was done. and a second monitoring for two weeks followed (W2, W3). Rats were then randomly divided into two groups: eight control rats received, via a mini-osmotic pump implanted subcutaneously, the excipient saline; the other eight rats received L-Dopa (100 mg/kg SC/day). After a seven-day period (W4), the pumps were removed and the T, HR, and A rhythms were monitored for two weeks (W5 and W6). To control for 6-OHDA striatal dopamine-induced depletion, 12 other rats were injected by identical methods (eight rats with 6-OHDA and four controls with saline) and sacrificed at W1, W3, and W5 for dopamine striatal content determination. To verify the delivery of levodopa from the osmotic pumps, plasma levels of levodopa and its main metabolites 3-OMD, DOPAC, and HVA were determined on separate group of rats receiving the drug under the same experimental conditions (osmotic pumps delivering continuously 10 microl/h for seven days, 100 mg/kg/subcutaneously). Our results agree with previously reported rhythmic changes induced by 6-OHDA--loss of circadian rhythmicity or changes in the main parameters of the registered rhythms. When circadian rhythmicity was abolished, L-Dopa treatment improved or accelerated recovery of the circadian rhythms, the effect being more pronounced for the HR rhythm. When circadian rhythms were not abolished but perturbed, L-Dopa treatment did not improve the 6-OHDA-induced changes in the T and A mesor (24 h mean level), while a significant effect was observed for HR. It appears that constant-rate L-Dopa infusion is unable to totally balance dopamine depletion; taking into account the circadian pattern of many structures implicated in drug effect, a sinusoidal delivery of L-Dopa must be evaluated in future experiments.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20370468     DOI: 10.3109/07420521003664213

Source DB:  PubMed          Journal:  Chronobiol Int        ISSN: 0742-0528            Impact factor:   2.877


  12 in total

Review 1.  Circadian and sleep disorders in Parkinson's disease.

Authors:  Aleksandar Videnovic; Diego Golombek
Journal:  Exp Neurol       Date:  2012-08-23       Impact factor: 5.330

2.  Global depletion of dopamine using intracerebroventricular 6-hydroxydopamine injection disrupts normal circadian wheel-running patterns and PERIOD2 expression in the rat forebrain.

Authors:  Luciana Gravotta; Alex M Gavrila; Suzanne Hood; Shimon Amir
Journal:  J Mol Neurosci       Date:  2011-04-12       Impact factor: 3.444

3.  Non-dipping nocturnal blood pressure and psychosis parameters in Parkinson disease.

Authors:  E Stuebner; E Vichayanrat; D A Low; C J Mathias; S Isenmann; C A Haensch
Journal:  Clin Auton Res       Date:  2015-02-18       Impact factor: 4.435

Review 4.  A New Perspective for Parkinson's Disease: Circadian Rhythm.

Authors:  Siyue Li; Yali Wang; Fen Wang; Li-Fang Hu; Chun-Feng Liu
Journal:  Neurosci Bull       Date:  2016-12-19       Impact factor: 5.203

Review 5.  Circadian system - A novel diagnostic and therapeutic target in Parkinson's disease?

Authors:  Aleksandar Videnovic; Gregory L Willis
Journal:  Mov Disord       Date:  2016-01-30       Impact factor: 10.338

6.  Circadian Dysregulation in Parkinson's Disease.

Authors:  Aleksandar Videnovic; Diego Golombek
Journal:  Neurobiol Sleep Circadian Rhythms       Date:  2016-11-12

7.  CLOCK 3111T/C Variant Correlates with Motor Fluctuation and Sleep Disorders in Chinese Patients with Parkinson's Disease.

Authors:  Fan Lou; Ming Li; Xiaoguang Luo; Yan Ren
Journal:  Parkinsons Dis       Date:  2018-02-04

8.  Circadian Clock Protein Content and Daily Rhythm of Locomotor Activity Are Altered after Chronic Exposure to Lead in Rat.

Authors:  Mariam Sabbar; Ouria Dkhissi-Benyahya; Abdelhamid Benazzouz; Nouria Lakhdar-Ghazal
Journal:  Front Behav Neurosci       Date:  2017-09-22       Impact factor: 3.558

9.  Parkinson's disease, lights and melanocytes: looking beyond the retina.

Authors:  Gregory L Willis; Cleo Moore; Stuart Maxwell Armstrong
Journal:  Sci Rep       Date:  2014-01-29       Impact factor: 4.379

10.  Propolis as A Potential Disease-Modifying Strategy in Parkinson's Disease: Cardioprotective and Neuroprotective Effects in the 6-OHDA Rat Model.

Authors:  Valeria C Gonçalves; Daniel J L L Pinheiro; Tomás de la Rosa; Antônio-Carlos G de Almeida; Fúlvio A Scorza; Carla A Scorza
Journal:  Nutrients       Date:  2020-05-26       Impact factor: 5.717

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.